Skip to content
Menu

HC Wainwright & Co. Maintains Buy on Fractyl Health, Raises Price Target to $24

Benzinga Newsdesk 4 days ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

HC Wainwright & Co. analyst Joseph Pantginis maintains Fractyl Health (NASDAQ:GUTS) with a Buy and raises the price target from $8 to $24.

HC Wainwright & Co. analyst Joseph Pantginis maintains Fractyl Health (NASDAQ:GUTS) with a Buy and raises the price target from $8 to $24.

Read at benzinga.com